Picture of Quidelortho logo

QDEL Quidelortho Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

Annual income statement for Quidelortho, fiscal year end - December 28th, USD millions except per share, conversion factor applied.

2021
December 31st
2023
December 31st
2023
January 1st
2024
December 29th
2025
December 28th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,6992,9983,2662,7832,730
Cost of Revenue
Gross Profit1,2711,4941,9361,2871,274
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses7922,8592,4464,7443,655
Operating Profit906139820-1,961-924
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes900-29.1736-2,132-1,108
Provision for Income Taxes
Net Income After Taxes704-10.1549-2,052-1,132
Net Income Before Extraordinary Items
Net Income704-10.1549-2,052-1,132
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income704-10.1549-2,052-1,132
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS16.61.1411.7-10.9-7.21